查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595271

Peri -植體炎市場：按類型、最終用戶分類 - 全球預測 2025-2030

Peri-implantitis Market by Type (Non-Surgical, Surgical), End-User (Dental Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，周邊-植體炎市值為9.5671億美元，預計2024年將達到10.5004億美元，複合年成長率為9.84%，到2030年將達到18.4654億美元。

植體周圍植入是一種影響人工植牙周圍組織的發炎疾病，由於老化和口腔健康意識增強導致植入手術數量不斷增加，對牙科領域構成了重大挑戰。它的定義是發炎導致骨質流失，威脅植入的穩定性。植體周圍植入可能會影響人工植牙的使用壽命，因此解決植體周圍炎需要強而有力的預防、診斷和治療應用。這些應用包括抗菌治療、機械清創和再生技術。最終用戶範圍從牙科診所到醫院再到研究機構，凸顯了醫療保健環境中需求的多樣性。市場成長受到牙科技術進步、患者對美容牙科解決方案的偏好增加以及研發方面的大量投資等因素的影響。特別是，在開發創新治療方法和再生解決方案以及利用遺傳和微生物知識的個人化醫療方法方面正在出現商機。牙科相關人員也在尋求先進的診斷工具以進行早期檢測，這為市場擴張提供了一個不斷成長的利基市場。然而，市場限制包括治療成本高、保險覆蓋範圍不足以及缺乏標準化治療通訊協定，這些都阻礙了廣泛採用。其他挑戰包括準確診斷植體周圍植入和有效治療晚期病例的複雜性。創新對於反應靈敏的植入的生醫材料開發、增強抗菌表面的奈米技術以及用於預測診斷的機器學習等領域至關重要。市場的性質仍然非常活躍，將牙科、生物技術和材料科學結合在一起的跨學科合作潛力巨大。公司需要透過專注於策略夥伴關係、對從業人員的繼續教育以及對研發的大量投資來保持領先地位。透過成功地探索這些維度，我們相信我們將能夠提高市場滲透率並在植體周圍植入的治療解決方案方面處於主導。

主要市場統計
基準年[2023] 95671萬美元
預測年份 [2024] 1,050,040,000 美元
預測年份 [2030] 18.4654億美元
複合年成長率（%） 9.84%

市場動態：快速發展的植入市場的關鍵市場洞察

供需的動態交互作用正在改變植體周圍植入市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 植入周圍炎盛行率增加
    • 吸煙和糖尿病人口迅速增加
    • 由於植入的增加導致老年人口增加
  • 市場限制因素
    • 缺乏手術相關知識與費用
  • 市場機會
    • 雷射去污等技術創新與進步
  • 市場挑戰
    • 臨床限制和功能挑戰

波特五力：駕馭植入周圍炎市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解植體周圍植入市場的外部影響

外部宏觀環境因素在影響植體周圍植入市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解植體周圍植入市場的競爭狀況

對植入周圍炎市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位植入植體周圍炎市場供應商的績效評估

FPNV 定位矩陣是評估植入市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和植入繪製植體周圍炎市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，植入周圍炎市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 植入周圍炎盛行率增加
      • 易患吸煙和糖尿病的人口迅速增加
      • 老年人口增加和人工植牙增加
    • 抑制因素
      • 缺乏手術知識和費用
    • 機會
      • 雷射去污等技術創新與進步
    • 任務
      • 臨床限制和功能挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章植入市場：依類型

  • 非手術的
    • 抗生素
    • 雷射清創術
    • 機械清創術
  • 外科手術
    • 骨再生
    • 植入術
    • 開瓣清創術

第7章植入周圍炎市場：依最終使用者分類

  • 牙醫診所
  • 醫院

第8章北美和南美植入周圍炎市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區植入周圍炎市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲植入周圍炎市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Aetna Inc.
  • Basic Pharma Life Science Pvt Ltd.
  • botiss biomaterials GmbH
  • Dawood & Tanner by Dentex Manco Limited
  • Geistlich Pharma AG
  • Healthy Life Pharma Pvt. Ltd.
  • Jiangsu Yenssen Biotech Co., Ltd.
  • Neoss Limited
  • Pfizer Inc.
  • Prachi Pharmaceuticals Private Limited.
  • Silveraid Srl
  • Small Lab Co., Ltd.
  • Straumann Group
  • vVARDIS AG
Product Code: MRR-4103B31E019B

The Peri-implantitis Market was valued at USD 956.71 million in 2023, expected to reach USD 1,050.04 million in 2024, and is projected to grow at a CAGR of 9.84%, to USD 1,846.54 million by 2030.

Peri-implantitis, an inflammatory condition affecting the tissues around dental implants, poses significant challenges in the field of dentistry, driven by increasing implant procedures due to aging populations and rising awareness of oral health. Its definition covers inflammation leading to bone loss, endangering implant stability. The necessity for addressing peri-implantitis lies in its potential to compromise the longevity of dental implants, necessitating robust prevention, diagnostic, and treatment applications. These applications encompass antimicrobial therapies, mechanical debridement, and regenerative techniques. End-users span dental clinics, hospitals, and research institutions, highlighting the diversified demand across healthcare settings. Market growth is influenced by factors like advancing dental technologies, increasing patient inclination towards aesthetic dental solutions, and substantial investments in R&D. Opportunities emerge particularly in developing innovative treatment modalities and regenerative solutions, along with personalized medicine approaches utilizing genetic and microbiomic insights. Dental professionals also push for advanced diagnostic tools for early detection, which presents a growing niche for market expansion. However, market limitations include high treatment costs, inadequate insurance coverage, and a lack of standardized treatment protocols, which hamper widespread adoption. Other challenging factors involve the complexity of diagnosing peri-implantitis accurately and effectively treating advanced cases. Innovation is crucial in areas like biomaterial development for more responsive implants, nanotechnology for enhanced antimicrobial surfaces, and machine learning for predictive diagnostics. The market's nature remains highly dynamic, with significant potential in interdisciplinary collaborations bringing together dentistry, biotechnology, and materials science. Firms should focus on strategic partnerships, continuous education for practitioners, and investing heavily in R&D to stay ahead. Successfully navigating these dimensions could lead to significant market penetration and leadership in peri-implantitis treatment solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 956.71 million
Estimated Year [2024] USD 1,050.04 million
Forecast Year [2030] USD 1,846.54 million
CAGR (%) 9.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peri-implantitis Market

The Peri-implantitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of peri-implantitis
    • Burgeoning population prone to smoking and diabetes
    • Rise in elderly populace coupled with increasing dental implants
  • Market Restraints
    • Lack of knowledge and cost linked with surgery
  • Market Opportunities
    • Technological innovation and advancements such as laser decontamination
  • Market Challenges
    • Clinical limitations and functional challenges

Porter's Five Forces: A Strategic Tool for Navigating the Peri-implantitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peri-implantitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peri-implantitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peri-implantitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peri-implantitis Market

A detailed market share analysis in the Peri-implantitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peri-implantitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peri-implantitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peri-implantitis Market

A strategic analysis of the Peri-implantitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peri-implantitis Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Aetna Inc., Basic Pharma Life Science Pvt Ltd., botiss biomaterials GmbH, Dawood & Tanner by Dentex Manco Limited, Geistlich Pharma AG, Healthy Life Pharma Pvt. Ltd., Jiangsu Yenssen Biotech Co., Ltd., Neoss Limited, Pfizer Inc., Prachi Pharmaceuticals Private Limited., Silveraid S.r.l., Small Lab Co., Ltd., Straumann Group, and vVARDIS AG.

Market Segmentation & Coverage

This research report categorizes the Peri-implantitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Non-Surgical and Surgical. The Non-Surgical is further studied across Antibiotics, Laser Debridement, and Mechanical Debridement. The Surgical is further studied across Bone Regeneration, Implanto-Plasty, and Open Flap Debridement.
  • Based on End-User, market is studied across Dental Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of peri-implantitis
      • 5.1.1.2. Burgeoning population prone to smoking and diabetes
      • 5.1.1.3. Rise in elderly populace coupled with increasing dental implants
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of knowledge and cost linked with surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovation and advancements such as laser decontamination
    • 5.1.4. Challenges
      • 5.1.4.1. Clinical limitations and functional challenges
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peri-implantitis Market, by Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
    • 6.2.1. Antibiotics
    • 6.2.2. Laser Debridement
    • 6.2.3. Mechanical Debridement
  • 6.3. Surgical
    • 6.3.1. Bone Regeneration
    • 6.3.2. Implanto-Plasty
    • 6.3.3. Open Flap Debridement

7. Peri-implantitis Market, by End-User

  • 7.1. Introduction
  • 7.2. Dental Clinics
  • 7.3. Hospitals

8. Americas Peri-implantitis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Peri-implantitis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Peri-implantitis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Aetna Inc.
  • 3. Basic Pharma Life Science Pvt Ltd.
  • 4. botiss biomaterials GmbH
  • 5. Dawood & Tanner by Dentex Manco Limited
  • 6. Geistlich Pharma AG
  • 7. Healthy Life Pharma Pvt. Ltd.
  • 8. Jiangsu Yenssen Biotech Co., Ltd.
  • 9. Neoss Limited
  • 10. Pfizer Inc.
  • 11. Prachi Pharmaceuticals Private Limited.
  • 12. Silveraid S.r.l.
  • 13. Small Lab Co., Ltd.
  • 14. Straumann Group
  • 15. vVARDIS AG

LIST OF FIGURES

  • FIGURE 1. PERI-IMPLANTITIS MARKET RESEARCH PROCESS
  • FIGURE 2. PERI-IMPLANTITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERI-IMPLANTITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERI-IMPLANTITIS MARKET DYNAMICS
  • TABLE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANTO-PLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY OPEN FLAP DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2023